Insys Therapeutics

Shares of Insys Therapeutics Inc (NASDAQ: INSY) plunged on Monday after the company provided preliminary first-quarter results. Insys Therapeutics, a specialty pharmaceutical company that develops supportive care products, announced that it expects its first-quarter revenue to fall in a range of $...

Shares of Insys Therapeutics Inc (NASDAQ: INSY) plunged more than 18 percent on Thursday. Roddy Boyd of SIRF wrote a scathing research report on Thursday titled "Murder Incorporated: Insys Therapeutics" in which he argued the company is ‘in a great deal of trouble.'...

Major indices were looking for a rebound after a four day skid which included multiple triple digit point losses for the Dow. Futures pointed to a higher opening as investors found reason to be positive in the House's passing of the budget agreement last night. The markets were unable to hold on...